- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01990638
Effects of Exercise Therapy on Ventricular and Endothelial Function in Patients After Coronary Artery Bypass Surgery
November 15, 2013 updated by: National Taiwan University Hospital
The purpose of this study was (1) to compare the peak exercise capacity and left ventricular diastolic function between patients with and without diabetes and (2) to investigate the interrelation among peak oxygen consumption, left ventricular diastolic function, blood sugar, and lipid profile.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
51
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 100
- National Taiwan University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients after coronary artery bypass surgery
Description
Inclusion Criteria:
- well-controlled diabetes
- no history of myocardial infarction
- stable post coronary artery bypass surgery for at least 3 months
Exclusion Criteria:
- heart failure,
- valvular disease,
- abnormal kidney or liver function,
- cerebrovascular disease,
- primary pulmonary disease,
- other systemic or acute illness that may impede the testing or training
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
DM group
|
|
non-DM group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
left ventricular diastolic function
Time Frame: 1 week
|
echocardiographic parameters
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
flow-mediated dilation
Time Frame: 1 week
|
flow-mediated dilation on right brachial artery
|
1 week
|
exercise capacity
Time Frame: 1 week
|
oxygen consumption
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Ying-Tai Wu, PhD, National Taiwan University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2004
Primary Completion (Actual)
April 1, 2005
Study Completion (Actual)
May 1, 2005
Study Registration Dates
First Submitted
November 15, 2013
First Submitted That Met QC Criteria
November 15, 2013
First Posted (Estimate)
November 21, 2013
Study Record Updates
Last Update Posted (Estimate)
November 21, 2013
Last Update Submitted That Met QC Criteria
November 15, 2013
Last Verified
November 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9361701193
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
AstraZenecaRecruiting
-
Daewoong Pharmaceutical Co. LTD.Not yet recruitingT2DM (Type 2 Diabetes Mellitus)
-
Zhongda HospitalRecruitingType 2 Diabetes Mellitus (T2DM)China
Clinical Trials on exercise capacity test
-
University of Campinas, BrazilCompleted
-
The Opole University of TechnologyCompleted
-
Hacettepe UniversityCompletedMucopolysaccharidosesTurkey
-
Hacettepe UniversityCompletedSurvivorship | Lung NeoplasmTurkey
-
Goksen Kuran AslanCompleted
-
Hacettepe UniversityCompletedHealthy | Obesity, ChildhoodTurkey
-
Hacettepe UniversityCompleted
-
Ankara Yildirim Beyazıt UniversityCompletedSports Physical TherapyTurkey
-
University of ZurichCompletedHigh Altitude Pulmonary Hypertension | Maximal Exercise CapacitySwitzerland
-
University Hospital, Clermont-FerrandCompletedLymphoma, Non-Hodgkin | Hodgkin Disease | Young AdultsFrance